FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX, Inc. (NYSE: MD), today announced the acquisitions of Medical Anesthesia Consultants, LLC, a private physician group practice based in Florence, S.C. and Anesthesia Associates of Naples, P.A., a private physician group practice based in Naples, Fla.
Established in 2007, Medical Anesthesia Consultants is a private practice that employs 20 anesthesiologists and provides anesthesia care across a wide spectrum of subspecialty areas including pediatrics, high-risk obstetrics, thoracic, cardiovascular, urology, neuro-anesthesia, orthopedics and acute pain management for post-operative pain. Medical Anesthesia Consultants is the exclusive provider of services to multiple facilities within the McLeod Health system including McLeod Regional Medical Center, McLeod Seacoast, McLeod Loris, McLeod Dillon and McLeod Health Cheraw.
“It’s ideal that we can maintain our clinical autonomy but be relieved of managing complex business and regulatory requirements,” said Gerald Hamrick, M.D., who will serve as medical director for the practice. “In addition, engaging in MEDNAX’s research, education and quality initiatives will help us further enhance the care we deliver.”
This acquisition adds to the services MEDNAX provides through its affiliated practices at McLeod Health which include neonatology, pediatric intensive care and newborn hearing screen, and in South Carolina across multiple specialties including anesthesia, neonatology, newborn hearing screening, pediatric intensive care and radiology.
In addition, Anesthesia Associates of Naples was established in 2007 and is a private practice that provides a broad range of subspecialty anesthesia services including gastroenterology, orthopedic, general surgery, urology and acute pain management for post-operative pain. The practice employs a clinical care team of eight full time anesthesiologists and 17 anesthetists, who provide services at Physicians Regional – Collier Boulevard and Physicians Regional-Pine Ridge, part of Community Health Systems.
“Joining MEDNAX will give us long-term stability in the rapidly changing health care environment and the support we need to manage insurance, billing, contract negotiations and other issues that were making it difficult to focus on what’s most important - practicing anesthesia and caring for patients,” said Chad Purdom, M.D., who will serve as medical director for the practice.
This acquisition adds to the services MEDNAX provides in Florida through its affiliated practices across multiple specialties including anesthesia, neonatology, maternal-fetal medicine, cardiology, pediatric intensive care, pediatric surgery, pediatric hospitalist, newborn hearing screen and radiology.
These practices were acquired for cash and the transactions are expected to be immediately accretive to earnings. No additional terms of these transactions were disclosed.
With these two acquisitions, 12 physician group practices have become part of MEDNAX in 2016.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,400 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.
